Back to Janus Henderson Group Ltd. Janus Henderson Group Ltd.

CMPX

14 quarters

Position history for Janus Henderson Group Ltd.Janus Henderson Group Ltd.'s holdings in Compass Therapeutics, Inc.

Yes. Janus Henderson holds 55,600 shares of CMPX (Compass Therapeutics), worth $293,846, as of its Q1 2026 13F filing. It opened the position in Q1 2026.

Current Value

$293,846

Current Shares

55,600

Total Value Change

-$4.4M

Total Shares Change

-1.4M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
New
55,600
-
$293,8460.0%$5.29
32
2024-Q4
Exited
0
-100.0%
$00.0%$1.45
0
2024-Q3
Decreased
1.8M
-64.7%
$3.4M0.0%$1.88
0
2024-Q2
Decreased
5.2M
-19.7%
$5.8M0.0%$1.00
0
2024-Q1
Decreased
6.5M
-0.8%
$12.8M0.0%$1.98
0
2023-Q4
Decreased
6.5M
-1.7%
$10.2M0.0%$1.56
0
2023-Q3
Increased
6.7M
+7.1%
$13.1M0.0%$1.97
30
2023-Q2
Increased
6.2M
+3.6%
$19.7M0.0%$2.98
29
2023-Q1
Increased
6M
+1.1%
$19.6M0.0%$3.19
29
2022-Q4
Increased
5.9M
+68.6%
$29.8M0.0%$5.03
43
2022-Q3
Increased
3.5M
+5.3%
$8.1M0.0%$2.22
29
2022-Q2
Increased
3.3M
+4.8%
$8.8M0.0%$2.67
29
2022-Q1
Increased
3.2M
+116.8%
$4.3M0.0%$1.33
43
2021-Q4
New
1.5M
-
$4.7M0.0%$3.00
37

Other major holders of CMPX: BlackRock, Inc., Adage Capital Partners GP, L.L.C., Vanguard Group Inc., State Street Corp.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used